AtriCure (ATRC) Tops Q2 EPS by 22c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
AtriCure Inc. (ATRC) PT Raised to $30 at Northland Capital Markets
August 2, 2018 1:30 PM EDTNorthland Capital Markets raised its price target on AtriCure Inc. (NASDAQ: ATRC) to $30.00 (from $25.00) while maintaining an Outperform rating.
Analyst Suraj Kalia commented, "Atricure' Q2-18 revenues of $51.8M were roughly in-line with our estimate @ $50.8M. Appendage mgmt continues to be... More
AtriCure Inc. (ATRC) PT Raised to $36 at Needham & Company
August 2, 2018 6:31 AM EDTNeedham & Company raised its price target on AtriCure Inc. (NASDAQ: ATRC) to $36.00 (from $32.00) while maintaining a Buy rating.
Analyst Mike Matson commented, "ATRC's 2Q18 revenue accelerated to 13.5% vs. 12.0% in 1Q18 and beat consensus. Management raised its 2018 revenue guidance to $193-197M... More



